{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:39:54Z","timestamp":1766428794414,"version":"3.33.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T00:00:00Z","timestamp":1178150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2007,6,7]]},"DOI":"10.1007\/s12012-007-0019-z","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T13:00:12Z","timestamp":1179147612000},"page":"160-164","source":"Crossref","is-referenced-by-count":18,"title":["Novel antioxidants in anthracycline cardiotoxicity"],"prefix":"10.1007","volume":"7","author":[{"given":"K\u00e1lm\u00e1n","family":"Hideg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"K\u00e1lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,3]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0005-2787(78)90059-X","volume":"519","author":"W. E. Ross","year":"1978","unstructured":"Ross, W. E., Glaubiger, D. L., & Kohn, K. W. (1978). Protein associated DNA breaks in cells treated with adriamycin or ellipticine. Biochimica et Biophysica Acta, 519, 23\u201330.","journal-title":"Biochimica et Biophysica Acta"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/bi00312a022","volume":"23","author":"R. P. Hertzberg","year":"1984","unstructured":"Hertzberg, R. P., & Dervan, P. B. (1984). Clevage of DNA with methidiumpropyl-EDTA-Iron(II)\u2013reaction conditions and procuct analyses. Biochemistry, 23, 3934\u20133945.","journal-title":"Biochemistry"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1021\/ar50088a003","volume":"8","author":"C. Walling","year":"1975","unstructured":"Walling, C. (1975). Fenton\u2019s reagent revisited. Accounts of Chemical Research, 8, 125\u2013131.","journal-title":"Accounts of Chemical Research"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0006-2952(95)00218-O","volume":"50","author":"B. B. Hasinoff","year":"1995","unstructured":"Hasinoff, B. B., Kuschak, T. I., Jalowich, J. C., & Creighton, A. M. (1995). A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (Dexrazoxane). Biochemical Pharmacology, 50, 953\u2013958.","journal-title":"Biochemical Pharmacology"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-199856030-00009","volume":"56","author":"L. R. Wiseman","year":"1998","unstructured":"Wiseman, L. R., & Spencer, C. M. (1998). Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Drugs, 56, 385\u2013403.","journal-title":"Drugs"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001813-200303000-00008","volume":"14","author":"C. E. Swenson","year":"2003","unstructured":"Swenson, C. E., Bolcsak, L. E., Batist, G., Guthrie, T. H., Tkaczuk, K. H., Boxenbaum, H., Welles, L., Show, S. C., Bhamra, R., & Chakin, P. (2003). Pharmacokinetics of doxorubicin administered i.v. as myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer. Anti-Cancer Drugs, 14, 239\u2013246.","journal-title":"Anti-Cancer Drugs"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00280-003-0667-z","volume":"52","author":"M. A. I. Abou El Hassan","year":"2003","unstructured":"Abou El Hassan, M. A. I., Kedde, M. A., Zwiers, U. T. H., Tourn, E., Haennen, G. R. M., Bast, A., & van der Vijgh, W. J. F. (2003). Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice. Cancer Chemotherapy and Pharmacology, 52, 371\u2013376.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0891-5849(96)00124-4","volume":"21","author":"E. Monti","year":"1996","unstructured":"Monti, E., Cova, D., Guido, E., Morelli, R., & Oliva, C. (1996). Protective effect of the nitroxide tempol against the cardiotoxicity of adriamycin. Free Radical Biology and Medicine, 21, 463\u2013470.","journal-title":"Free Radical Biology and Medicine"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0006-2952(94)90567-3","volume":"48","author":"W. DeGraff","year":"1994","unstructured":"DeGraff, W., Hahn, S. M., Mitchell, J. B., & Krishna, M. C. (1994). Free radical modes of cytotoxicity of adriamycin\u00ae and streptonigrin. Biochemical Pharmacology, 48, 1427\u20131435.","journal-title":"Biochemical Pharmacology"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/jm00157a005","volume":"29","author":"H. O. Hankovszky","year":"1986","unstructured":"Hankovszky, H. O., Hideg, K., B\u00f3di, I., & Frank, L. (1986). New Antiarrhythmic Agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethyl-pyrrolidine-3-carboxamides. Journal of Medicinal Chemistry, 29, 1138\u20131152.","journal-title":"Journal of Medicinal Chemistry"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0891-5849(96)00477-7","volume":"22","author":"P. Twomey","year":"1997","unstructured":"Twomey, P., Taira, J., DeGraff, W., Mitchell, J. B., Russo, A., Krishna, M. C., Hankovszky, H. O., Frank, L., & Hideg, K. (1997). Direct evidence for In\u00a0Vivo nitroxide free radical production from a new antiarrhythic drug by EPR spectroscopy. Free Radical Biology and Medicine, 22, 909\u2013916.","journal-title":"Free Radical Biology and Medicine"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0022-3565(24)35361-3","volume":"292","author":"R.A. Shankar","year":"2000","unstructured":"Shankar, R.A., Hideg, K., Zweier, J. L., & Kuppusamy, P. (2000). Targeted antioxidant properties of N-[(Tetramethyl-3-pyrroline-3-carboxamido) propylphthalimide, a new antiarrhythmic drug and its nitroxide-metabolite in preventing postischemic myocardial injury. Journal of Pharmacology and Experimental Therapeutics, 292, 838\u2013845.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00005344-200111000-00011","volume":"38","author":"Zs. Marton","year":"2001","unstructured":"Marton, Zs., Halmosi, R., Horv\u00e1th, B., Alexy, T., K\u00e9sm\u00e1rky, G., V\u00e9k\u00e1si, J., Batty\u00e1ny, I., Hideg, K., & T\u00f3th, K. (2001). Scavenger effect of experimental and clinically used cardiovascular drugs. Journal of Cardiovascular Pharmacolgy, 38, 745\u2013753.","journal-title":"Journal of Cardiovascular Pharmacolgy"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00005344-200501000-00007","volume":"45","author":"P. Deres","year":"2005","unstructured":"Deres, P., Halmosi, R., T\u00f3th, A., Kov\u00e1cs, K., P\u00e1lfi, A., Habon, T., Czopf, L., K\u00e1lai, T., Hideg, K., S\u00fcmegi, B., & T\u00f3th, K. (2005). Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. Journal of Cardiovascular Pharmacology, 45, 36\u201343.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15216540252774829","volume":"52","author":"A. Mordente","year":"2001","unstructured":"Mordente, A., Meucci, E. , Martorana, G. E., Giardina, B., & Minotti, G. (2001). Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life, 52, 83\u201388.","journal-title":"IUBMB Life"},{"key":"19_CR16","doi-asserted-by":"crossref","unstructured":"K\u00e1lai, T., Hideg, \u00c9., Vass, I. & Hideg, K. (1998) Double (Fluorescent and Spin) Sensors for detection of reactive oxygen species in the thylakoid membrane. Free Radical Biology and Medicine, 24, 649\u2013652.","DOI":"10.1016\/S0891-5849(97)00339-0"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"26026","DOI":"10.1074\/jbc.271.42.26026","volume":"271","author":"M. C. Krishna","year":"1996","unstructured":"Krishna, M. C., Russo, A., Mitchell, J. B., Goldstein, S., Hafini, H., & Samuni, A. (1996). Do nitroxide antioxidants act as scavengers of O 2 .\u2212 or as SOD mimics? Journal of Biological Chemistry, 271, 26026\u201326031.","journal-title":"Journal of Biological Chemistry"},{"key":"19_CR18","first-page":"110","volume":"A","author":"S. Goldstein","year":"2006","unstructured":"Goldstein, S., Samuni, A., Hideg, K., & Mer\u00e9nyi, G. (2006). Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. Journal of Physical Chemistry A, 110, 3679\u20133685.","journal-title":"Journal of Physical Chemistry"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1016689607579","volume":"14","author":"J. Glebska","year":"2001","unstructured":"Glebska, J., Pulaski, L., Gwozdzinski, K., & Kolimowski, J. (2001). Structure-activity relationship studies of protetive function of nitroxides in Fenton system. BioMetals, 14, 159\u2013170.","journal-title":"BioMetals"},{"key":"19_CR20","doi-asserted-by":"crossref","unstructured":"Zhang, R., Hirsch, O., Mohsen, M., & Samuni, A. (1994). Effects of nitroxide stable radicals on juglone cytotoxicity. Archives of Biochemistry and Biophysics, 312, 385\u2013391.","DOI":"10.1006\/abbi.1994.1323"},{"key":"19_CR21","first-page":"563","volume":"295","author":"H. Li","year":"2000","unstructured":"Li, H., Xu, K. Y., Zhou, L., K\u00e1lai, T., Zweier, J. L., Hideg, K., & Kuppusamy, P. (2000). A pyrroline derivative of mexiletine offers marked protection against ischemia\/reperfusion- induced myocardial contractile dysfunction. Journal of Pharmacology and Experimental Therapeutics, 295, 563\u2013571.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.freeradbiomed.2006.06.004","volume":"41","author":"Z. Bogn\u00e1r","year":"2006","unstructured":"Bogn\u00e1r, Z., K\u00e1lai, T., P\u00e1lfi, A., Hant\u00f3, K., Bogn\u00e1r, B., M\u00e1rk, L., Szab\u00f3, Z., Tapodi, A., Radnai, B., S\u00e1rszegi, Zs., Sz\u00e1nt\u00f3, \u00c1. Jr., Gallyas, F., Hideg, K., S\u00fcmegi, B., & V\u00e1rb\u00edr\u00f3, G. (2006). A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. Free Radical Biology and Medicine, 41, 835\u2013848.","journal-title":"Free Radical Biology and Medicine"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.105.100834","volume":"317","author":"V. K. Kutala","year":"2006","unstructured":"Kutala, V. K., Khan, M., Mandal, R., Ganesan, L. P., Tridandapani, S., K\u00e1lai, T., Hideg, K., & Kuppusamy, P. (2006). Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. Journal of Pharmacology and Experimental Therapeutics, 317, 921\u2013928.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1039\/b509865c","volume":"3","author":"T. K\u00e1lai","year":"2005","unstructured":"K\u00e1lai, T., Mugesh, G., Roy, G., Sies, H., Berente, Z., & Hideg, K. (2005). Combining benzol[d]isoselenazol-3-ones with sterically hindered alicyclic amines and nitroxides: enhanced activity as glutathione peroxidase mimics. Organic Biomolecular Chemistry, 3, 3564\u20133569.","journal-title":"Organic Biomolecular Chemistry"},{"key":"19_CR25","doi-asserted-by":"crossref","unstructured":"J\u00e1szber\u00e9nyi, Z., Br\u00fccher, E., Jek\u0151, J., Hideg, K., K\u00e1lai, T. & Kir\u00e1ly, R. (2003). Synthesis, equilibrium and kinetic properties of the Gd3+ complexes of three spin labeled DTPA-bis(amide) derivative ligands. European Journal of Inorganic Chemistry, 2003, 3601\u20133608.","DOI":"10.1002\/ejic.200300059"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-007-0019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-007-0019-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-007-0019-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:48:27Z","timestamp":1737013707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-007-0019-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6,7]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s12012-007-0019-z","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"type":"print","value":"1530-7905"},{"type":"electronic","value":"1559-0259"}],"subject":[],"published":{"date-parts":[[2007,5,3]]}}}